NRX PHARMACEUTICALS INC (NRXP) — institutional ownership

50 funds reported holding NRX PHARMACEUTICALS INC in their latest 13F filings, worth $52.2M in total (CUSIP 629444209).

Largest holders

1. B Group, Inc. — $16.7M
2. VANGUARD CAPITAL MANAGEMENT LLC — $6.62M
3. CITADEL ADVISORS LLC — $3.81M
4. AMERIPRISE FINANCIAL INC (AMP) — $3.80M
5. BALYASNY ASSET MANAGEMENT L.P. — $3.66M
6. AdvisorShares Investments LLC — $2.70M
7. VANGUARD GROUP INC — $1.98M
8. COMMONWEALTH EQUITY SERVICES, LLC — $1.86M
9. UBS Group AG (UBS) — $1.73M
10. GEODE CAPITAL MANAGEMENT, LLC — $1.29M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Two Sigma portfolio (Two Sigma Investments)
• Izzy Englander portfolio (Millennium Management)

Insider buying and selling at NRX PHARMACEUTICALS INC

Who owns the most NRXP stock?

The largest institutional holders in the latest 13F filings are B Group, Inc. ($16.7M), VANGUARD CAPITAL MANAGEMENT LLC ($6.62M), CITADEL ADVISORS LLC ($3.81M).

How many funds own NRXP?

50 funds reported holding it, worth $52.2M in total.